NFKB1 and leukemia: The main issues raised by researchers in the context of the possibility of using exosomal ncRNAs in the therapy of leukemia include the influence of miRNAs on the modification of the microenvironment of leukemic cells through the ability to modify T lymphocytes in patients with leukemia [31,32], the influence on angiogenesis processes [39,60], and the influence on important signaling pathways from the point of view of leukemogenesis, such as NF-κB, Wnt/β-catenin, and NOTCH [46,57,61].